Community/Retail

Household cleaning and disinfectant use has increased in homes as a result of the coronavirus disease 2019 (COVID-19) pandemic.

Pharmacy Times® interviewed Samir Balile, PharmD, on the safety measures Giant pharmacies are taking to protect patients and staff members upon reopening their doors, as well as the importance of the flu vaccine during COVID-19.

Results from 2 initial phase 3 studies evaluating an investigational 15-valent pneumococcal conjugate vaccine were recently released, assessing its immunogenicity, safety, and tolerability.

The Pharmacy Health Information Collaborative is currently accepting comments from stakeholders.

According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.

FDA guidance encourages diverse study pools at all phases of development.

A statewide Indiana study shows that 47% of people are using technology to communicate with their health care providers, and less than a quarter are having conversations with their providers about using health information technology (HIT).

Women are more likely to receive multiple opioid prescriptions, study finds.

New research indicates that even with effective antiretroviral treatment, HIV may still affect the central nervous system.

The findings include airway inflammation and rapid development of pulmonary edema, coronary artery aneurysms, and extensive intra-abdominal inflammatory changes, according to the study authors.

Collaboration between pharmacists and general practice teams improves patient care and increases savings.

A new heart valve combines the biocompatibility of a biological valve with the robustness of a mechanical one.

Remdesivir, the investigational drug for the treatment of the coronavirus disease 2019 (COVID-19), will be sold for $390 per vial.

Some states are implementing laws that are allowing pharmacists to expand their roles temporarily, but these laws vary by state and there is no uniformity in what all pharmacists can do during this time.

COVID-19 attacks the cardiovascular system and may exasperate preexisting heart conditions.

Current research has already found that CVD is among the most common pre-existing conditions among people who die from COVID-19.

The paper is an update to previous guidelines released by ACSM and the American Heart Association in 1998.

Studying blood samples from critically ill patients at the London Health Sciences Center (LHSC), the researchers identified a unique pattern of 6 molecules that could be used as therapeutic targets to treat the virus, as reported in the Critical Care Explorations journal.

The measles, mumps, and rubella vaccine may hold the key to the mystery surrounding children and the COVID-19 pandemic.

The pharmaceutical industry is already seeing the immense benefit of AI and machine-learning technology.

Many companies are working with health systems to transition patients from the hospital to in-home care as quickly as possible.

According to the survey results, not only do a majority of the 500 respondents experience fear of bleeding events, but many of them also avoid or modify activities in order to mitigate their risk.

Although researchers know that HIV enters the brain within 8 days of infection, less is known about whether HIV-infected brain cells can release the virus, letting it migrate from the brain back into the body to infect other tissues.

Pharmacists, being the most accessible health care professionals, have an important role to play in the management of this pandemic.

Although some of the largest insurers have waived their cost sharing requirements, employer-sponsored “self-insured” health insurance plans are not required to adhere to these waivers.

The NIA is currently funding more than 230 active clinical trials on AD and related dementias. Of those, more than 100 are nondrug interventions, such as exercise, diet, cognitive training, sleep, or combination therapies.

Researchers looked at the effects of a genetic risk score for developing T2D as an adult on metabolism, measured from blood samples taken from participants in the study when they were aged 8, 16, 18, and 25 years.

Being able to predict life expectancy will help care providers decide which A1c target ranges are the best for each patient with diabetes.

Planning on how to address drug and equipment shortages will be essential to continuing patient care in the coming months.

The dupilumab pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration.